Swiss pharma giant Roche announced today its decision to proceed with Phase III development of prasinezumab, an ...

A second case of acute liver failure (ALF) resulting in the death has been reported in a young recipient of Elevidys ...

French drug developer Averoa today announced that the European Commission (EC) has granted marketing authorization for ...

TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...

French pharma major Sanofi and US partner Regeneron Pharmaceuticals yesterday presented positive results from the EVEREST ...

China’s National Medical Products Administration (NMPA) held a meeting last week to conduct the 2024 annual review of the ...

Californian biotech Jasper Therapeutics presented data from the 180mg cohort of the company’s SPOTLIGHT Phase Ib/IIa study of ...

With exports valued at 105.5 billion Swiss francs ($130.2 billion) and a 38.5% share of total exports, the pharmaceutical ...

Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...

Boston, USA-based biotech Solu Therapeutics today announced the appointment of Enda Moran as chief operating officer (COO).

A clinical-stage biotech company based in Redwood City, California, developing tissue-restorative biologics for chronic ...

Formed in 2024 by ADQ, a sovereign wealth fund, Arcera consolidates several pharmaceutical businesses, including Acino ...